Anal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 20, Issue SUPPL. 4, 2009, Pages

  Glynne Jones, R ^a   Northover, J ^b   Oliveira, J ^c  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

^c INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ANUS CANCER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER RISK; CANCER STAGING; DISEASE SURVEILLANCE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECTOSCOPY; RISK ASSESSMENT; SALVAGE THERAPY; SEX DIFFERENCE; TREATMENT RESPONSE; VIRUS INFECTION;

ANUS NEOPLASMS; EUROPE; FOLLOW-UP STUDIES; HEALTH PLANNING GUIDELINES; HUMANS; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 66549107680     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp129     Document Type: Article

References (12)

1. Greene FL, Page DL, Fleming ID et al. (eds). AJCC Staging Manual, 6th edition. New York: Springer 2002; 125-130.
2. Engstrom PF, Amoletti JP, Benson AB et al. Available at www.nccn.org/ professionals/physician_gls/PDF/anal.pdf (last accessed March 13, 2008).
3. Ajani JA, Winter KA, Gunderson LL et al. Fluorouracil, mitomycin and radiotherapy vs fluorouracil, cisplatin and radiotherapy for carcinoma of the anal canal: A randomised controlled trial. JAMA 2008; 199: 1914-1921.
4. Nigro ND, Seydel HG, Considine B Jr et al. Combined radiotherapy and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 1983; 51: 1826-1829.
5. Cummings BJ, Keane TJ, O'Sullivan B et al. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991; 21: 1115-1125.
6. Bartelink H, Roelofsen F, Eschwege F et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997; 15: 2040-2049.es
7. UKCCCR Anal Cancer Working Party. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin C. Lancet 1996; 348: 1049-1054.
8. Flam M, John M, Pajak TF et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 1996; 14: 2527-2539.
9. Bosset JF, Roelefsen F, Morgan D et al. Shortened irradiation scheme, continuous infusion of fluorouracil in locally advanced anal carcinomas: results of a phase II study of the European Organization for Research and Treatment of Cancer. Eur J Cancer 2003; 39: 45-51.
10. Crehange G, Bosset M, Lorchel F et al. Combining cisplatin and mitomycin with radiotherapy in anal carcinoma. Dis Colon Rectum 2006; 50: 43-49.
11. James R, Meadows H, Wan S. ACT II: The second UK phase III anal cancer trial. Clin Oncol 2005; 17: 364-366.
12. John M, Pajak T, Flam M et al. Dose escalation in chemoradiation for anal cancer: Preliminary results of RTOG 92-08. Cancer J Sci Am 1996; 2: 205-210.